http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#Head
http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#assertion
http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#provenance
http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#pubinfo
http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#assertion
http://purl.obolibrary.org/obo/DOID_4989
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_4989
http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00900
http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#association
http://www.w3.org/2000/01/rdf-schema#label
"Coadministration with stavudine allopurinol or ribavirin is contraindicated. ( 4 VIDEX EC is contraindicated when coadministered with the following medications: Stavudine- potential for serious and/or life-threatening events, notably pancreatitis, lactic acidosis, hepatotoxicity, and peripheral neuropathy [ see Warnings and Precautions 5.1 5.2 5.3 5.5 Allopurinol- systemic exposures of didanosine are increased, which may increase didanosine-associated toxicity [ see Clinical Pharmacology (12.3) Ribavirin- exposures of the active metabolite of didanosine (dideoxyadenosine 5'-triphosphate) are increased. Fatal hepatic failure, as well as peripheral neuropathy, pancreatitis, and symptomatic hyperlactatemia/lactic acidosis have been reported in patients receiving both didanosine and ribavirin."
http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#association
https://w3id.org/biolink/vocab/relation
https://schema.org/MedicalContraindication
https://identifiers.org/drugbank:DB00900
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#provenance
http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#pubinfo
http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#sig
http://purl.org/nanopub/x/hasSignature
Z0p4ng4ay2tqerdaaoCmOrIr3hqPej9UFwlEJYUQGn85yaSJuI0TYa04j3Wdd7BPnPP+E9pP8wYHkqGdXoHroUA7bATCO+hKHcBsWlMnuvo4b6VZKp75q6aH/ARlXUqZRLFvcKgEh5Q0mOXa4Pg/j96+n+m4CNltTU/tmFASl1Y=
http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8
http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8
http://purl.org/dc/terms/created
2021-08-25T14:00:28.988+02:00
http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY